![SI150060: Osimertinib-13C d3 label-new Fmoc-Thr([Gal β(1-4)Glc]Ac7)-OH](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/SI150060.svg?v=1701111287)
Pay in 4 interest-free payments of $193.75 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Fmoc-Thr([Gal β(1-4)Glc]Ac7)-OH
equipped with an azide handle through a hydrophilic PEG3 spacer
/ Fmoc-Thr(Gal(Ac)4-β-D)-OH / Fmoc-Thr(β-D-Gal)-OH
6-dioxaoctyl) 2
Tn-antigen
SI150060: Osimertinib-13C d3 label-new Fmoc-Thr([Gal β(1-4)Glc]Ac7)-OHC2713CH30D3N7O2 503. 64 Lung Cancer Osimertinib 13C d3 Mereletinib d6; AZD9291 d6; Tagrisso d6; N (2 {2 dimethylaminoethyl methylamino} 4 methoxy 5 {[4 (1 methylindol 3 yl)pyrimidin 2 yl]amino}phenyl)prop 2 enamide d6; [13C,2H3] Osimertinib
US$ 130.00
US$ 185.00
US$ 188.00
US$ 129.95
